Publications Office of the EU
CSC F 13/24 - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

CSC F 13/24

  • Published
    05/02/2025
  • Deadline
    10/03/2025
  • Today
    15/03/2025
  • Opening of tenders
    17/03/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Consorci de Salut i d'AtenciĆ³ Social de Catalunya
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: ES511 Barcelona
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
2,171,556.99 EUR
Total final contract value (excluding VAT)
Not available
Tender reference number
Not available
Description

Acuerdo Marco del Suministro de MEDICAMENTOS ANTISƉPTICOS DESTINADOS AL CAMPO QUIRƚRGICO PREOPERATORIO Y A LA DESINFECCIƓN DEL PUNTO DE INYECCIƓN

Submission Method
Electronic via:
https://contractaciopublica.cat/ca/perfils-contractant/detall/8885209?categoria=0
Tenders may be submitted
Electronic submission: required
https://contractaciopublica.cat/ca/perfils-contractant/detall/8885209?categoria=0
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
17/03/2025 10:30
Place of performance
Award method
Not available
Estimated value
2,171,556.99 EUR
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.